Developing abuse-deterrent prescription drugs for CNS disorders.
Industry: Health Care
First Day Return: -6.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/23/2020 |
Offer Price | $8.00 |
Price Range $8.00 - $10.00 | |
Offer Shares (mm) | 2.3 |
Deal Size ($mm) | $18 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/09/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $18 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Philadelphia, PA, United States |
Founded | 2018 |
Employees at IPO | 2 |
Website www.vallon-pharma.com |